Literature DB >> 32049009

Transcriptional Programs Define Intratumoral Heterogeneity of Ewing Sarcoma at Single-Cell Resolution.

Marie-Ming Aynaud1, Olivier Mirabeau1, Nadege Gruel2, Sandrine Grossetête1, Valentina Boeva3, Simon Durand1, Didier Surdez1, Olivier Saulnier1, Sakina Zaïdi1, Svetlana Gribkova4, Aziz Fouché5, Ulykbek Kairov6, Virginie Raynal1, Franck Tirode7, Thomas G P Grünewald2, Mylene Bohec8, Sylvain Baulande8, Isabelle Janoueix-Lerosey1, Jean-Philippe Vert9, Emmanuel Barillot10, Olivier Delattre11, Andrei Zinovyev12.   

Abstract

EWSR1-FLI1, the chimeric oncogene specific for Ewing sarcoma (EwS), induces a cascade of signaling events leading to cell transformation. However, it remains elusive how genetically homogeneous EwS cells can drive the heterogeneity of transcriptional programs. Here, we combine independent component analysis of single-cell RNA sequencing data from diverse cell types and model systems with time-resolved mapping of EWSR1-FLI1 binding sites and of open chromatin regions to characterize dynamic cellular processes associated with EWSR1-FLI1 activity. We thus define an exquisitely specific and direct enhancer-driven EWSR1-FLI1 program. In EwS tumors, cell proliferation and strong oxidative phosphorylation metabolism are associated with a well-defined range of EWSR1-FLI1 activity. In contrast, a subpopulation of cells from below and above the intermediary EWSR1-FLI1 activity is characterized by increased hypoxia. Overall, our study reveals sources of intratumoral heterogeneity within EwS tumors.
Copyright © 2020 The Authors. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  EWSR1-FLI1; Ewing sarcoma; Independent Component Analysis; intratumor heterogeneity; patient-derived xenografts; single-cell RNA-sequencing; time series; transcriptomics

Mesh:

Substances:

Year:  2020        PMID: 32049009     DOI: 10.1016/j.celrep.2020.01.049

Source DB:  PubMed          Journal:  Cell Rep            Impact factor:   9.423


  29 in total

1.  Systems Biology Analysis for Ewing Sarcoma.

Authors:  Marianyela Petrizzelli; Jane Merlevede; Andrei Zinovyev
Journal:  Methods Mol Biol       Date:  2021

2.  Single-cell RNA profiling identifies diverse cellular responses to EWSR1/FLI1 downregulation in Ewing sarcoma cells.

Authors:  Roxane Khoogar; Fuyang Li; Yidong Chen; Myron Ignatius; Elizabeth R Lawlor; Katsumi Kitagawa; Tim H-M Huang; Doris A Phelps; Peter J Houghton
Journal:  Cell Oncol (Dordr)       Date:  2022-01-07       Impact factor: 6.730

3.  EWS/FLI mediated reprogramming of 3D chromatin promotes an altered transcriptional state in Ewing sarcoma.

Authors:  Iftekhar A Showpnil; Julia Selich-Anderson; Cenny Taslim; Megann A Boone; Jesse C Crow; Emily R Theisen; Stephen L Lessnick
Journal:  Nucleic Acids Res       Date:  2022-09-23       Impact factor: 19.160

4.  In vivo 3D profiling of site-specific human cancer cell morphotypes in zebrafish.

Authors:  Dagan Segal; Hanieh Mazloom-Farsibaf; Bo-Jui Chang; Philippe Roudot; Divya Rajendran; Stephan Daetwyler; Reto Fiolka; Mikako Warren; James F Amatruda; Gaudenz Danuser
Journal:  J Cell Biol       Date:  2022-09-26       Impact factor: 8.077

Review 5.  Epigenetic and Transcriptional Signaling in Ewing Sarcoma-Disease Etiology and Therapeutic Opportunities.

Authors:  Mingli Li; Chun-Wei Chen
Journal:  Biomedicines       Date:  2022-06-05

6.  STAG2 loss rewires oncogenic and developmental programs to promote metastasis in Ewing sarcoma.

Authors:  Biniam Adane; Gabriela Alexe; Bo Kyung A Seong; Diana Lu; Elizabeth E Hwang; Denes Hnisz; Caleb A Lareau; Linda Ross; Shan Lin; Filemon S Dela Cruz; Melissa Richardson; Abraham S Weintraub; Sarah Wang; Amanda Balboni Iniguez; Neekesh V Dharia; Amy Saur Conway; Amanda L Robichaud; Benjamin Tanenbaum; John M Krill-Burger; Francisca Vazquez; Monica Schenone; Jason N Berman; Andrew L Kung; Steven A Carr; Martin J Aryee; Richard A Young; Brian D Crompton; Kimberly Stegmaier
Journal:  Cancer Cell       Date:  2021-06-14       Impact factor: 38.585

7.  Reconstruction of Ewing Sarcoma Developmental Context from Mass-Scale Transcriptomics Reveals Characteristics of EWSR1-FLI1 Permissibility.

Authors:  Henry E Miller; Aparna Gorthi; Nicklas Bassani; Liesl A Lawrence; Brian S Iskra; Alexander J R Bishop
Journal:  Cancers (Basel)       Date:  2020-04-11       Impact factor: 6.639

Review 8.  The YAP/TAZ Pathway in Osteogenesis and Bone Sarcoma Pathogenesis.

Authors:  Heinrich Kovar; Lisa Bierbaumer; Branka Radic-Sarikas
Journal:  Cells       Date:  2020-04-15       Impact factor: 6.600

9.  Unraveling Ewing Sarcoma Tumorigenesis Originating from Patient-Derived Mesenchymal Stem Cells.

Authors:  Didier Surdez; Erika Brunet; Anna Sole; Sandrine Grossetête; Maxime Heintzé; Loelia Babin; Sakina Zaïdi; Patrick Revy; Benjamin Renouf; Anne De Cian; Carine Giovannangeli; Cécile Pierre-Eugène; Isabelle Janoueix-Lerosey; Lucile Couronné; Sophie Kaltenbach; Mark Tomishima; Maria Jasin; Thomas G P Grünewald; Olivier Delattre
Journal:  Cancer Res       Date:  2021-08-02       Impact factor: 12.701

Review 10.  Breakthrough Technologies Reshape the Ewing Sarcoma Molecular Landscape.

Authors:  Carmen Salguero-Aranda; Ana Teresa Amaral; Joaquín Olmedo-Pelayo; Juan Diaz-Martin; Enrique de Álava
Journal:  Cells       Date:  2020-03-26       Impact factor: 6.600

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.